Two Sigma Ventures, L.P. is an investment fund managing more than $9.61 million ran by Jon Dietrich. There is currently 1 company in Mr. Dietrich’s portfolio. The largest and only investment include Recursion Pharmaceuticals In worth $9.61 million.
As of 7th November 2022, Two Sigma Ventures, L.P.’s top holding is 903,400 shares of Recursion Pharmaceuticals In currently worth over $9.61 million and making up 100.0% of the portfolio value.
Currently, Two Sigma Ventures, L.P.'s portfolio is worth at least $9.61 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Two Sigma Ventures, L.P. office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Jon Dietrich serves as the Chief Compliance Officer at Two Sigma Ventures, L.P..
There are companies that Two Sigma Ventures, L.P. is getting rid of from its portfolio.
Two Sigma Ventures, L.P. closed its position in Zymergen Inc on 14th November 2022.
It sold the previously owned 1,513,727 shares for $1.86 million.
Jon Dietrich also disclosed a decreased stake in Recursion Pharmaceuticals In by 0.5%.
This leaves the value of the investment at $9.61 million and 903,400 shares.
The two most similar investment funds to Two Sigma Ventures, L.P. are Tokio Marine & Nichido Fire Insurance Co., Ltd and Numen Capital LL.P.. They manage $9.66 million and $9.68 million respectively.
These positions were updated on November 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Recursion Pharmaceuticals In |
50.00%
903,400
|
$9,612,000 | 100.00% |
| Zymergen Inc |
Closed
1,513,727
|
$1,862,000 | |
| No transactions found | |||
| Showing first 500 out of 2 holdings | |||